Durafiber AG

DURAFIBER Ag is indicated as an absorbent, antimicrobial gelling dressing for the management of chronic and acute, full thickness, partial thickness, or shallow granulating exuding wounds. For example: leg ulcers; pressure ulcers; diabetic ulcers; surgical wounds; traumatic wounds; donor sites; partial thickness burns; tunnelling and fistulae wounds; wounds left to heal by secondary intent; and wounds that are prone to bleeding such as wounds that have been surgically or mechanically debrided.

DURAFIBER Ag is designed to be left in place for up to 7 days.

DURAFIBER Ag may be used on infected wounds. Where the product is used on infected wounds the infection should be inspected and treated as per local protocol.

• Clinicians/Healthcare Professionals should be aware that there are very limited data on prolonged and repeated use of silver containing dressings, particularly in children and neonates.

• Whilst DURAFIBER Ag assists in the management of wounds prone to minor bleeding, it is not intended to be used as a surgical sponge in heavily bleeding wounds.

• DURAFIBER Ag is not compatible with oil-based products such as petrolatum.

• Avoid contact with electrodes or conductive gels during electronic measurements e.g. EEG and ECG.

• Ensure that packing in cavities sinuses etc. has been removed.

• The dressing may not be compatible with topical antimicrobials.

• If reddening or sensitisation occurs discontinue use.

• In the event of clinical infection, topical silver does not replace the need for systemic therapy or other adequate infection treatment.

• When DURAFIBER Ag is used on a patient during MRI (Magnetic Resonance Imaging) examination some warming may be experienced.

• DURAFIBER Ag may cause transient discoloration of the surrounding skin.

1. Cleanse the wound according to local clinical protocol.

2. Select appropriate dressing size.

3. Remove the DURAFIBER Ag dressing from pack, using a clean technique. Cut to shape if necessary.

4. Apply the dressing to the wound and allow for a 1cm / 1/3in.dressing overlap onto the skin surrounding the wound.

5. When using DURAFIBER Ag in deep cavity wounds use whole dressings where possible and leave at least 2.5cm / 1in. of each piece outside the wound for easy retrieval.

6. Loosely pack deep wounds up to 80% capacity, as DURAFIBER Ag will expand on contact with wound fluid.

7. Secure DURAFIBER Ag with a moisture retentive dressing (e.g. ALLEVYN/OPSITE) or other appropriate secondary retention.

8. The dressing can be removed in one piece using sterile tweezers, forceps or a gloved hand.

9. The dressing may adhere if used on lightly exuding wounds. If the dressing is not easily removed, moisten or soak the dressing in sterile saline to assist removal and avoid disruption of the healing wound.

During the early stages of wound management, DURAFIBER dressings should be inspected frequently. Dressings can be left undisturbed for up to 7 days or changed when clinically indicated, (e.g. if leakage, excessive bleeding is present). Local clinical protocol should also be taken into consideration. DURAFIBER Ag is a single use product. If used on more than one patient, cross-contamination or infection may result. Opening the dressing pack compromises the sterile barrier. Any unused dressing should be discarded.